SAN FRANCISCO, Aug. 14, 2024 (GLOBE NEWSWIRE) -- Excision BioTherapeutics, Inc. (“Excision”, the “Company”), a clinical-stage biotechnology company developing CRISPR-based therapies to cure serious ...
SAN FRANCISCO, Oct. 12, 2021 (GLOBE NEWSWIRE) -- Excision BioTherapeutics Inc., a biotechnology company developing CRISPR-based therapies intended to cure viral infectious diseases, today announced ...
When Heather Guidone learned she had endometriosis in the 1980s, she had never heard of it. “The doctor said, ‘Well, the good news is we have a diagnosis. The bad news is you’re probably not going to ...
This Journal feature begins with a case vignette that includes a therapeutic recommendation. A discussion of the clinical problem and the mechanism of benefit of this form of therapy follows. Major ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results